Issue of Equity

RNS Number : 1576R
ValiRx PLC
16 August 2010
 



ValiRx Plc

("ValiRx" or the "Company")

 

 

Issue of Equity

 

ValiRx announces that, on 13 August 2010, the Company issued 7,407,333 new ordinary shares of 0.1p each ("Ordinary Shares") to Cancer Research Technology Limited ("CRT") at an issue price of 0.45p per share, being the mid-market price of the Ordinary Shares on 13 August 2010.  The share issue was in respect of the payment of milestones and other payments due to CRT according to the terms and conditions of the option agreement entered into in 2008 with CRT and the subsequent  licensing agreement with CRT signed on 11 August 2010.

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 19 August 2010. Following the issue of the new Ordinary Shares, the total number of Ordinary Shares now in issue is 343,923,790.

 

 

For further information, please contact:

 

ValiRx plc


Dr. Satu Vainikka

Tel: +44 (0) 20 3008 4416


www.ValiRx.com



WH Ireland Limited - Nominated Adviser


Robin Gwyn

Tel: +44 (0) 161 832 2174



Hybridan LLP - Broker


Claire Noyce

Tel: +44 (0) 207 947 4350



Peckwater PR


Tarquin Edwards

Tel: +44 (0)7879 458 364


tarquin.edwards@peckwaterpr.co.uk

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQQLFFBVFFBBF

Companies

Valirx (VAL)
UK 100

Latest directors dealings